OBJECTIVE: To compare coronary flow reserve in endurance athletes and healthy sedentary controls, using adenosine transthoracic echocardiography. METHODS: 29 male endurance athletes (mean (SD) age 27.3 (6.6) years, body mass index (BMI) 22.1 (1.9) kg/m(2)) and 23 male controls (age 27.2 (6.1) years, BMI 23.9 (2.6) kg/m(2)) with no coronary risk factors underwent transthoracic echocardiographic assessment of distal left anterior descending coronary artery (LAD) diameter and flow, both at rest and during intravenous adenosine infusion (140 microg/kg/min). RESULTS: Distal LAD diameter and flow were adequately assessed in 19 controls (83%) and 26 athletes (90%). Distal LAD diameter in athletes (2.04 (0.25) mm) was not significantly greater than in sedentary controls (1.97 (0.27) mm). Per cent increase in LAD diameter following 400 microg sublingual nitrate was greater in the athletes than in the controls, at 14.1 (7. 2)% v 8.8 (5.7)% (p < 0.01). Left ventricular mass index in athletes exceeded that of controls, at 130 (19) v 98 (14) g/m(2) (p < 0.01). Resting flow among the athletes (10.6 (3.1) ml/min; 4.4 (1.2) ml/min/100 g left ventricular mass) was less than in the controls (14.3 (3.6) ml/min; 8.2 (2.2) ml/min/100 g left ventricular mass) (both p < 0.01). Hyperaemic flow among the athletes (61.9 (17.8) ml/min) exceeded that of the controls (51.1 (14.6) ml/min; p = 0.02), but not when corrected for left ventricular mass (25.9 (5.6) v 28.5 (7.4) ml/min/100 g left ventricular mass; NS). Coronary flow reserve was therefore substantially greater in the athletes than in the controls, at 5.9 (1.0) v 3.7 (0.7) (p < 0.01). CONCLUSIONS: Coronary flow reserve in endurance athletes is supranormal and endothelium independent vasodilatation is enhanced. Myocardial hypertrophy per se does not necessarily impair coronary flow reserve. Adenosine transthoracic echocardiography is a promising technique for the investigation of coronary flow reserve.
OBJECTIVE: To compare coronary flow reserve in endurance athletes and healthy sedentary controls, using adenosine transthoracic echocardiography. METHODS: 29 male endurance athletes (mean (SD) age 27.3 (6.6) years, body mass index (BMI) 22.1 (1.9) kg/m(2)) and 23 male controls (age 27.2 (6.1) years, BMI 23.9 (2.6) kg/m(2)) with no coronary risk factors underwent transthoracic echocardiographic assessment of distal left anterior descending coronary artery (LAD) diameter and flow, both at rest and during intravenous adenosine infusion (140 microg/kg/min). RESULTS: Distal LAD diameter and flow were adequately assessed in 19 controls (83%) and 26 athletes (90%). Distal LAD diameter in athletes (2.04 (0.25) mm) was not significantly greater than in sedentary controls (1.97 (0.27) mm). Per cent increase in LAD diameter following 400 microg sublingual nitrate was greater in the athletes than in the controls, at 14.1 (7. 2)% v 8.8 (5.7)% (p < 0.01). Left ventricular mass index in athletes exceeded that of controls, at 130 (19) v 98 (14) g/m(2) (p < 0.01). Resting flow among the athletes (10.6 (3.1) ml/min; 4.4 (1.2) ml/min/100 g left ventricular mass) was less than in the controls (14.3 (3.6) ml/min; 8.2 (2.2) ml/min/100 g left ventricular mass) (both p < 0.01). Hyperaemic flow among the athletes (61.9 (17.8) ml/min) exceeded that of the controls (51.1 (14.6) ml/min; p = 0.02), but not when corrected for left ventricular mass (25.9 (5.6) v 28.5 (7.4) ml/min/100 g left ventricular mass; NS). Coronary flow reserve was therefore substantially greater in the athletes than in the controls, at 5.9 (1.0) v 3.7 (0.7) (p < 0.01). CONCLUSIONS: Coronary flow reserve in endurance athletes is supranormal and endothelium independent vasodilatation is enhanced. Myocardial hypertrophy per se does not necessarily impair coronary flow reserve. Adenosine transthoracic echocardiography is a promising technique for the investigation of coronary flow reserve.
Authors: P Clarkson; H E Montgomery; M J Mullen; A E Donald; A J Powe; T Bull; M Jubb; M World; J E Deanfield Journal: J Am Coll Cardiol Date: 1999-04 Impact factor: 24.094
Authors: T Hozumi; K Yoshida; T Akasaka; Y Asami; Y Ogata; T Takagi; S Kaji; T Kawamoto; Y Ueda; S Morioka Journal: J Am Coll Cardiol Date: 1998-11 Impact factor: 24.094
Authors: Dick H J Thijssen; Andrew J Maiorana; Gerry O'Driscoll; Nigel T Cable; Maria T E Hopman; Daniel J Green Journal: Eur J Appl Physiol Date: 2009-11-27 Impact factor: 3.078
Authors: Ilkka Heinonen; Sergey V Nesterov; Kaisa Liukko; Jukka Kemppainen; Kjell Någren; Matti Luotolahti; Pauliina Virsu; Vesa Oikonen; Pirjo Nuutila; Urho M Kujala; Heikki Kainulainen; Robert Boushel; Juhani Knuuti; Kari K Kalliokoski Journal: J Physiol Date: 2008-09-04 Impact factor: 5.182
Authors: Theodoros D Karamitsos; Sairia Dass; Joseph Suttie; Emily Sever; Jacqueline Birks; Cameron J Holloway; Matthew D Robson; Michael Jerosch-Herold; Hugh Watkins; Stefan Neubauer Journal: J Am Coll Cardiol Date: 2013-03-19 Impact factor: 24.094
Authors: Akos Koller; M Harold Laughlin; Edina Cenko; Cor de Wit; Kálmán Tóth; Raffaele Bugiardini; Danijela Trifunovits; Marija Vavlukis; Olivia Manfrini; Adam Lelbach; Gabriella Dornyei; Teresa Padro; Lina Badimon; Dimitris Tousoulis; Stephan Gielen; Dirk J Duncker Journal: Cardiovasc Res Date: 2022-01-29 Impact factor: 13.081